Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemorrhagic Disorders × Calcium Dobesilate × Clear all

Sponsor

Conditions

Multiple Myeloma 91 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Burkitt Lymphoma 17 Lymphoma 16 Leukemia 15 Recurrence 14 Neoplasms, Plasma Cell 12 Nausea 12 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Vomiting 11 Waldenstrom Macroglobulinemia 10 Breast Neoplasms 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Neoplasms 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 7 Immunoglobulin Light-chain Amyloidosis 7 Hodgkin Disease 7 Smoldering Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Amyloidosis 6 Prostatic Neoplasms 5 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Biphenotypic, Acute 4

Interventions

sonidegib 1 ruxolitinib 1 Vorinostat 1 Bortezomib 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡